Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C | NEJM
Original Article from The New England Journal of Medicine — Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
Original Article from The New England Journal of Medicine — Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
A 47-year-old man was incidentally found to have diffuse nodular opacities on chest radiography. He had worked in a quarry for more than 30 years.
Hounded by questions about her love life, a young physician finds relief in the isolation imposed by the Covid pandemic, while she gains an education…
A 62-year-old man presented with a 1-month history of muscle aches in the legs and weight loss. Abdominal angiography revealed aneurysms and irregularity of the…
Editorial from The New England Journal of Medicine — Cell-free DNA for Colorectal Cancer Screening
Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis by means of ex vivo clustered regularly interspaced short palindromic repeats…
U.S. health plans that aim to address members’ social needs face a host of regulatory obstacles whose management requires deep engagement by institutional compliance offices.
A 47-year-old man was incidentally found to have diffuse nodular opacities on chest radiography. He had worked in a quarry for more than 30 years.
The use of thrombectomy in patients with acute stroke and a large infarct of unrestricted size has not been well studied. We assigned, in a…
People may be able to wait longer between colonoscopies, and a trial evaluates a less invasive option for treating prostate cancer.
This award recognizes an investigator whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment or…